Looking to sell Unlearn stock or options?
Unlearn develops machine-learning models that generate digital twins to populate intelligent control arms in clinical trials. By using AI to create synthetic patient data, the company's technology speeds up clinical studies by supplementing control groups. This approach reduces the time needed to develop new medications, allowing healthcare companies to deliver life-saving therapies to patients more swiftly.
8VC, Necessary Ventures, EPIC Ventures, Mubadala Capital, DCVC Bio, Insight Partners, Parkway Venture Capital, DCVC, Eisai Innovation, Altimeter Capital Management, Alumni Ventures, Wittington Ventures, Radical Ventures.
Unlearn is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Unlearn stock. Depending on Unlearn’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Unlearn stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Unlearn stock in two ways. First, Unlearn employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Unlearn stock. Note that all transactions in Unlearn shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Unlearn stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Unlearn stock. Typically, shares of private companies like Unlearn are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jan 2024, Unlearn is reported to have closed an equity financing in which the investors valued the company at $368M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Unlearn shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Unlearn is not currently publicly traded, it does not have a ticker symbol.
Unlearn has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Unlearn is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Unlearn shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.